tiprankstipranks
Trending News
More News >
Novo Nordisk (DE:NOV)
XETRA:NOV

Compare Novo Nordisk (NOV) vs. Competitors

Compare
610 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Novo Nordisk
€50.62
€225.24B
16.47
-37.77%
6 Buy
5 Hold
1 Sell
Moderate Buy
Novo Nordisk
kr385.22
kr1.68T
16.51
-37.65%
6 Buy
5 Hold
1 Sell
Moderate Buy
AstraZeneca
14008.00p
£218.93B
30.17
29.44%
12 Buy
2 Hold
1 Sell
Moderate Buy
Marks Electrical Group Plc
46.00p
£48.80M
-44.71
-12.26%
0 Buy
1 Hold
0 Sell
Hold
GlaxoSmithKline
1858.00p
£75.72B
13.73
39.59%
3 Buy
8 Hold
4 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:NOV
Novo Nordisk
51.50
-27.32
-34.66%
GB:0QIU
Novo Nordisk
385.22
-196.79
-33.81%
GB:AZN
AstraZeneca
14,008.00
3,393.82
31.97%
GB:MRK
Marks Electrical Group Plc
46.50
-6.67
-12.54%
GB:GSK
GlaxoSmithKline
1,858.00
566.32
43.84%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts